These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 28887235)

  • 21. An antagonist of substance P N-terminal fragments, D-substance P(1-7), reveals that both nociceptive and antinociceptive effects are induced by substance P N-terminal activity during noxious chemical stimulation.
    Goettl VM; Larson AA
    Brain Res; 1998 Jan; 780(1):80-5. PubMed ID: 9473599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shanzhiside methylester, the principle effective iridoid glycoside from the analgesic herb Lamiophlomis rotata, reduces neuropathic pain by stimulating spinal microglial β-endorphin expression.
    Fan H; Li TF; Gong N; Wang YX
    Neuropharmacology; 2016 Feb; 101():98-109. PubMed ID: 26363192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spinal astrocytic c-Jun N-terminal kinase (JNK) activation as counteracting mechanism to the amitriptyline analgesic efficacy in painful peripheral neuropathies.
    Sanna MD; Ghelardini C; Galeotti N
    Eur J Pharmacol; 2017 Mar; 798():85-93. PubMed ID: 28119076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting Neuropathic Pain: Pathobiology, Current Treatment and Peptidomimetics as a New Therapeutic Opportunity.
    Caroleo MC; Brizzi A; De Rosa M; Pandey A; Gallelli L; Badolato M; Carullo G; Cione E
    Curr Med Chem; 2020; 27(9):1469-1500. PubMed ID: 31142248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of peripheral inflammation by the substance P N-terminal metabolite substance P1-7.
    Wiktelius D; Khalil Z; Nyberg F
    Peptides; 2006 Jun; 27(6):1490-7. PubMed ID: 16414148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-allodynic effect of 2-(aminomethyl)adamantane-1-carboxylic acid in a rat model of neuropathic pain: a mechanism dependent on CaV2.2 channel inhibition.
    Zoidis G; Sandoval A; Pineda-Farias JB; Granados-Soto V; Felix R
    Bioorg Med Chem; 2014 Mar; 22(6):1797-803. PubMed ID: 24582401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-hyperalgesic and anti-allodynic activities of capillarisin via suppression of inflammatory signaling in animal model.
    Khan S; Shehzad O; Chun J; Choi RJ; Park S; Islam MN; Choi JS; Kim YS
    J Ethnopharmacol; 2014 Mar; 152(3):478-86. PubMed ID: 24495472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pretreatment with antiserum against dynorphin, substance P, or cholecystokinin enhances the morphine-produced anti-allodynia in the sciatic nerve ligated mice.
    Wu HE; Schwasinger ET; Hong JS; Tseng LF
    Neurosci Lett; 2005 Sep; 386(1):46-51. PubMed ID: 15982809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-nociceptive, anti-hyperalgesic and anti-arthritic activity of amides and extract obtained from Piper amalago in rodents.
    da Silva Arrigo J; Balen E; Júnior UL; da Silva Mota J; Iwamoto RD; Barison A; Sugizaki MM; Leite Kassuya CA
    J Ethnopharmacol; 2016 Feb; 179():101-9. PubMed ID: 26723468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropathic pain and reactive gliosis are reversed by dialdehydic compound in neuropathic pain rat models.
    Bianco MR; Cirillo G; Petrosino V; Marcello L; Soleti A; Merizzi G; Cavaliere C; Papa M
    Neurosci Lett; 2012 Nov; 530(1):85-90. PubMed ID: 22981978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PC1, a non-peptide PKR1-preferring antagonist, reduces pain behavior and spinal neuronal sensitization in neuropathic mice.
    Guida F; Lattanzi R; Boccella S; Maftei D; Romano R; Marconi V; Balboni G; Salvadori S; Scafuro MA; de Novellis V; Negri L; Maione S; Luongo L
    Pharmacol Res; 2015 Jan; 91():36-46. PubMed ID: 25434589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curcumin exerts antinociceptive effects in a mouse model of neuropathic pain: descending monoamine system and opioid receptors are differentially involved.
    Zhao X; Xu Y; Zhao Q; Chen CR; Liu AM; Huang ZL
    Neuropharmacology; 2012 Feb; 62(2):843-54. PubMed ID: 21945716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TRR469, a potent A(1) adenosine receptor allosteric modulator, exhibits anti-nociceptive properties in acute and neuropathic pain models in mice.
    Vincenzi F; Targa M; Romagnoli R; Merighi S; Gessi S; Baraldi PG; Borea PA; Varani K
    Neuropharmacology; 2014 Jun; 81():6-14. PubMed ID: 24486382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The C-terminal amidated analogue of the substance P (SP) fragment SP(1-7) attenuates the expression of naloxone-precipitated withdrawal in morphine dependent rats.
    Zhou Q; Carlsson A; Botros M; Fransson R; Sandström A; Gordh T; Hallberg M; Nyberg F
    Peptides; 2009 Dec; 30(12):2418-22. PubMed ID: 19686790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioactive peptidic analogues and cyclostereoisomers of the minimal antinociceptive histogranin fragment-(7-10).
    Le HT; Lemaire IB; Gilbert AK; Jolicoeur F; Lemaire S
    J Med Chem; 2003 Jul; 46(14):3094-101. PubMed ID: 12825947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
    Desroches J; Charron S; Bouchard JF; Beaulieu P
    Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The N-terminal domain of substance P is required for complete homologous desensitization but not phosphorylation of the rat neurokinin-1 receptor.
    Vigna SR
    Neuropeptides; 2001 Feb; 35(1):24-31. PubMed ID: 11346307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-nociceptive synergism of morphine and gabapentin in neuropathic pain induced by chronic constriction injury.
    De la O-Arciniega M; Díaz-Reval MI; Cortés-Arroyo AR; Domínguez-Ramírez AM; López-Muñoz FJ
    Pharmacol Biochem Behav; 2009 May; 92(3):457-64. PubMed ID: 19463259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of substance P transport across the blood-brain barrier.
    Chappa AK; Audus KL; Lunte SM
    Pharm Res; 2006 Jun; 23(6):1201-8. PubMed ID: 16729222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-hyperalgesic and anti-nociceptive potentials of standardized grape seed proanthocyanidin extract against CCI-induced neuropathic pain in rats.
    Kaur G; Bedi O; Sharma N; Singh S; Deshmukh R; Kumar P
    J Basic Clin Physiol Pharmacol; 2016 Jan; 27(1):9-17. PubMed ID: 26378488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.